TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -12.98%11.31B | 21.68%25.01B | 28.81%13B | -6.51%20.56B | -6.77%10.09B | 46.61%21.99B | 69.07%10.83B | -15.44%15B | -32.89%6.4B | -5.69%17.74B |
Operating income | -12.98%11.31B | 21.68%25.01B | 28.81%13B | -6.51%20.56B | -6.77%10.09B | 46.61%21.99B | 69.07%10.83B | -15.44%15B | -32.89%6.4B | -5.69%17.74B |
Cost of sales | 13.33%-8.11B | -21.60%-18.41B | -29.79%-9.36B | 7.86%-15.14B | 14.28%-7.21B | -51.06%-16.43B | -81.09%-8.42B | 16.06%-10.88B | 33.29%-4.65B | 8.58%-12.96B |
Operating expenses | 13.33%-8.11B | -21.60%-18.41B | -29.79%-9.36B | 7.86%-15.14B | 14.28%-7.21B | -51.06%-16.43B | -81.09%-8.42B | 16.06%-10.88B | 33.29%-4.65B | 8.58%-12.96B |
Gross profit | -12.07%3.2B | 21.91%6.6B | 26.35%3.64B | -2.51%5.42B | 19.44%2.88B | 34.86%5.56B | 37.25%2.41B | -13.76%4.12B | -31.79%1.76B | 3.16%4.78B |
Selling expenses | 6.04%-2.04B | -10.56%-4.25B | -16.78%-2.18B | -2.47%-3.85B | -28.74%-1.86B | -51.40%-3.75B | -27.04%-1.45B | 10.94%-2.48B | 18.58%-1.14B | -0.34%-2.78B |
Administrative expenses | 2.56%-445.93M | -12.68%-971.53M | -8.56%-457.64M | -5.61%-862.23M | -13.86%-421.56M | -24.31%-816.43M | -21.12%-370.23M | 4.28%-656.77M | 9.93%-305.67M | -11.84%-686.12M |
Special items of operating profit | -102.79%-4.54M | 182.99%106.16M | 45.74%162.52M | 4.73%37.51M | -32.25%111.52M | -2.50%35.82M | 434.61%164.61M | 110.99%36.74M | 1,874.98%30.79M | -469.82%-334.19M |
Operating profit | -39.69%703.46M | 99.45%1.48B | 65.31%1.17B | -27.10%744.19M | -6.84%705.53M | 0.09%1.02B | 121.48%757.31M | 4.88%1.02B | -59.18%341.93M | -26.46%972.45M |
Financing income | 59.35%15.15M | 31.60%17.56M | 34.35%9.51M | -1.96%13.34M | --7.08M | --13.61M | ---- | ---- | ---- | ---- |
Financing cost | -11.66%-70.27M | -58.68%-129.9M | -88.69%-62.93M | -35.34%-81.86M | -10.85%-33.35M | 20.56%-60.49M | 25.78%-30.09M | 14.61%-76.14M | -3.00%-40.54M | ---89.16M |
Special items of earning before tax | 53.89%-22.82M | 82.51%-14.5M | -4.22%-49.48M | -360.58%-82.91M | ---47.48M | --31.82M | ---- | ---- | ---- | ---- |
Earning before tax | -41.18%625.53M | 129.00%1.36B | 68.32%1.06B | -41.06%592.76M | -13.12%631.78M | 6.57%1.01B | 141.29%727.22M | 6.84%943.75M | -62.24%301.39M | -33.22%883.29M |
Tax | 46.18%-129.93M | -165.45%-310.59M | -55.92%-241.43M | 55.90%-117M | 18.65%-154.84M | 12.90%-265.33M | -100.15%-190.34M | -27.05%-304.61M | 48.10%-95.1M | 22.76%-239.76M |
After-tax profit from continuing operations | -39.71%495.6M | 120.04%1.05B | 72.35%822M | -35.74%475.76M | -11.17%476.94M | 15.84%740.38M | 160.25%536.88M | -0.68%639.14M | -66.45%206.3M | -36.43%643.53M |
After-tax profit from non-continuing business | 1,473.86%24.18M | -40.07%-47.68M | 81.42%-1.76M | 66.17%-34.04M | -928.77%-9.48M | -6.27%-100.61M | -118.12%-921K | ---94.67M | --5.08M | ---- |
Earning after tax | -36.63%519.78M | 126.20%999.18M | 75.47%820.24M | -30.96%441.72M | -12.78%467.46M | 17.50%639.77M | 153.55%535.96M | -15.39%544.46M | -65.63%211.38M | -36.43%643.53M |
Minority profit | 10.81%-6.21M | -27.28%-13.5M | -61.83%-6.97M | -204.01%-10.6M | -2,974.29%-4.3M | ---3.49M | ---140K | ---- | ---- | ---- |
Shareholders should account for profits from continuing business | -39.47%501.81M | 118.02%1.06B | 72.26%828.97M | -34.62%486.37M | -10.39%481.24M | 16.39%743.87M | 160.32%537.02M | --639.14M | --206.3M | ---- |
Shareholders should account for profits from non-continuing business | 1,473.86%24.18M | -40.07%-47.68M | 81.42%-1.76M | 66.17%-34.04M | -928.77%-9.48M | -6.27%-100.61M | -118.12%-921K | ---94.67M | --5.08M | ---- |
Profit attributable to shareholders | -36.41%525.99M | 123.88%1.01B | 75.34%827.21M | -29.68%452.33M | -12.00%471.76M | 18.15%643.26M | 153.62%536.1M | -15.39%544.46M | -65.63%211.38M | -36.43%643.53M |
Basic earnings per share | -36.45%0.776 | 123.80%1.495 | 75.43%1.221 | -29.68%0.668 | -12.01%0.696 | 18.16%0.95 | 153.53%0.791 | -15.37%0.804 | -65.64%0.312 | -36.41%0.95 |
Diluted earnings per share | -36.45%0.776 | 123.80%1.495 | 75.43%1.221 | -29.68%0.668 | -12.01%0.696 | 18.16%0.95 | 153.53%0.791 | -15.37%0.804 | -65.64%0.312 | -36.41%0.95 |
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.